medisourceasia.com

Industry News


About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Medical Devices Being Marketed Without Regulations, Safeguards In India

India still does not have a comprehensive set of rules for the manufacture and marketing of medical devices despite their increasing therapeutic in human bodies for several years. The Central Drugs Standard Control Organisation (CDSCO) has been working on to frame specific standards for licensing of these products for more than 16 months now.

In the absence of a set of rules or any guidelines, the state drugs control authorities in the country are in total confusion with regard to the standards for licensing the 10 medical devices notified as drugs by the Central government in October 2005. The notified products are very much available in the market without licence.

Senior drug control officials said that the authorities have failed to issue a single licence for the notified products so far. Although some of the states have commenced inspection of storage and manufacturing premises as per the directive of a sub-committee under the CDSCO, the state authorities are groping in the dark on the standards and guidelines for issuing product licence, they said.

Moreover, the Drugs Controller General of India (DCGI) has issued a circular to the state drugs controllers seeking information to take policy decisions on the issue after the October notification came into effect and the 60 day period allowed for manufacturers to submit application. The letter dated September 21, 2006 seeks information like number of applications received, the details of inspection carried out jointly with CDSCO, details of guidelines followed for such inspection and whether any experts were involved in the inspection.

"The aforesaid information is required in order to take policy decision about the procedures, standards requirements to be adopted for grant licences to medical devices," reveals the letter in possession with Pharmabiz. "This show that the CDSCO itself is in confusion on the procedure to be taken. And it also reveals that the authority has not furnished any solid guidelines even after the period of implementation started from October 2006. Around 80 percent of these notified products available in the markets at present doesn't have any approval but we cannot take action because of the DCGI's guidelines," said a drug control official from Andhra Pradesh.

"Currently the only guideline we have Schedule M and we are inspecting the companies as per these norms. There is no other guideline with us specifically for medical devices licensing. There are a number of players in the segment, either as manufacturer or more as distributors and we are on the process of inspecting the sites," said a senior official from Gujarat FDA.

"We have sent the applications to the CDSCO and are conducting inspection in distribution and manufacturing centres according to their suggestion. But the details for licensing are yet to be cleared by the central authority. It seems that the central authority is on a deceleration in the issue," another official from Kerala Drug Control Administration informed.

Though product licensing is under purview of the state drugs control organization, the inspection are to be conducted in association with the CDSCO zonal officers. The CDSCO with strength of 40 officials for the entire country has to accompany the state officials in inspection simultaneously with its existing workload.

The CDSCO West zone has conducted inspection on around 35 units in January 2007, though the officials informed that not a single licence for the notified products has been issued till date. The officials informed that only around eight units would pass through approval, while all the other applicants withdrew applications in a later stage.

(Ref : Chronicle Pharmabiz dated February 22, 2007)


Next
 

Other News

Govt Plans Regulation Of Retail Pharmacies
Corporate Hospitals See 15% Earnings From Foreign Patients
Heart Connect
GE Healthcare To Augment Product Dept Capability
Labelling Committee Moots Country Wise Code For Drug Exports
Kitten To Market Timestripís Smart Label Technology In India
Borealis Develops Polypropylene BH34MO For Pail Packaging
AMDSI Urges Govt To Reduce Customs Duty, Set Up Medical Tech Park
AIOCD To Float 10 State Wise Pharmacy Retail Chain Cos By 2008
Companies Look To Gain From Budget Proposals
US FDA Nod For Baxter's Colleague Infusion Pump
Polymed Medicure Eyeing US Market

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next